Effects of repeated amphetamine treatment on regional GABAA receptor binding
The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml,...
Gespeichert in:
Veröffentlicht in: | Brain research 1999-04, Vol.825 (1-2), p.180-182 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 182 |
---|---|
container_issue | 1-2 |
container_start_page | 180 |
container_title | Brain research |
container_volume | 825 |
creator | GRUEN, R. J STOKER, S FRIEDHOFF, A. J BRADBERRY, C. W |
description | The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization. |
doi_str_mv | 10.1016/S0006-8993(99)01150-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69713876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69713876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</originalsourceid><addsrcrecordid>eNpNkE1PhDAQhhujcdfVn6DhYIwe0A6FQo-4WT-STTyo52Yow4qBgi178N_LfkQ9Td7JMx95GDsHfgsc5N0r51yGmVLiWqkbDpDwUB6wKWRpFMoo5ods-otM2In3n2MUQvFjNgEegYQsmbLloqrIDD7oqsBRTzhQGWDbf9CAbW0pGNzYa8kOQWdHYlV3FpvgMb_P8zEa6ofOBUVty9quTtlRhY2ns32dsfeHxdv8KVy-PD7P82VooiiTYUGliWWCsZBlIRUAzwBBoDIFpiAAMSsMlmmiYohQIJgyprRKpISEqEzFjF3t9vau-1qTH3Rbe0NNg5a6tddSjWuyVI5gsgON67x3VOne1S26bw1cbzTqrUa9caSV0luNejN3sT-wLloq_03tvI3A5R5Ab7CpHFpT-z9u_D2JMvEDZCZ6Lw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69713876</pqid></control><display><type>article</type><title>Effects of repeated amphetamine treatment on regional GABAA receptor binding</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>GRUEN, R. J ; STOKER, S ; FRIEDHOFF, A. J ; BRADBERRY, C. W</creator><creatorcontrib>GRUEN, R. J ; STOKER, S ; FRIEDHOFF, A. J ; BRADBERRY, C. W</creatorcontrib><description>The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(99)01150-6</identifier><identifier>PMID: 10216185</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier</publisher><subject>Adrenergic Agents - pharmacology ; Amphetamine - pharmacology ; Animals ; Biological and medical sciences ; Brain Chemistry - drug effects ; Cerebellum - chemistry ; GABA Antagonists - pharmacology ; Hypothalamus - chemistry ; Locomotion - physiology ; Male ; Medical sciences ; Neostriatum - chemistry ; Neuropharmacology ; Pharmacology. Drug treatments ; Prefrontal Cortex - chemistry ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Pyridazines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, GABA-A - metabolism ; Receptors, GABA-A - physiology ; Tritium</subject><ispartof>Brain research, 1999-04, Vol.825 (1-2), p.180-182</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright 1999 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</citedby><cites>FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1759528$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10216185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GRUEN, R. J</creatorcontrib><creatorcontrib>STOKER, S</creatorcontrib><creatorcontrib>FRIEDHOFF, A. J</creatorcontrib><creatorcontrib>BRADBERRY, C. W</creatorcontrib><title>Effects of repeated amphetamine treatment on regional GABAA receptor binding</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization.</description><subject>Adrenergic Agents - pharmacology</subject><subject>Amphetamine - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain Chemistry - drug effects</subject><subject>Cerebellum - chemistry</subject><subject>GABA Antagonists - pharmacology</subject><subject>Hypothalamus - chemistry</subject><subject>Locomotion - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neostriatum - chemistry</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prefrontal Cortex - chemistry</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Pyridazines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, GABA-A - metabolism</subject><subject>Receptors, GABA-A - physiology</subject><subject>Tritium</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE1PhDAQhhujcdfVn6DhYIwe0A6FQo-4WT-STTyo52Yow4qBgi178N_LfkQ9Td7JMx95GDsHfgsc5N0r51yGmVLiWqkbDpDwUB6wKWRpFMoo5ods-otM2In3n2MUQvFjNgEegYQsmbLloqrIDD7oqsBRTzhQGWDbf9CAbW0pGNzYa8kOQWdHYlV3FpvgMb_P8zEa6ofOBUVty9quTtlRhY2ns32dsfeHxdv8KVy-PD7P82VooiiTYUGliWWCsZBlIRUAzwBBoDIFpiAAMSsMlmmiYohQIJgyprRKpISEqEzFjF3t9vau-1qTH3Rbe0NNg5a6tddSjWuyVI5gsgON67x3VOne1S26bw1cbzTqrUa9caSV0luNejN3sT-wLloq_03tvI3A5R5Ab7CpHFpT-z9u_D2JMvEDZCZ6Lw</recordid><startdate>19990417</startdate><enddate>19990417</enddate><creator>GRUEN, R. J</creator><creator>STOKER, S</creator><creator>FRIEDHOFF, A. J</creator><creator>BRADBERRY, C. W</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990417</creationdate><title>Effects of repeated amphetamine treatment on regional GABAA receptor binding</title><author>GRUEN, R. J ; STOKER, S ; FRIEDHOFF, A. J ; BRADBERRY, C. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2286-bedc465a436db6911081a13a9cba7131aa8bcad759412a3a1cd4e7f56615eed73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adrenergic Agents - pharmacology</topic><topic>Amphetamine - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain Chemistry - drug effects</topic><topic>Cerebellum - chemistry</topic><topic>GABA Antagonists - pharmacology</topic><topic>Hypothalamus - chemistry</topic><topic>Locomotion - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neostriatum - chemistry</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prefrontal Cortex - chemistry</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Pyridazines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, GABA-A - metabolism</topic><topic>Receptors, GABA-A - physiology</topic><topic>Tritium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GRUEN, R. J</creatorcontrib><creatorcontrib>STOKER, S</creatorcontrib><creatorcontrib>FRIEDHOFF, A. J</creatorcontrib><creatorcontrib>BRADBERRY, C. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GRUEN, R. J</au><au>STOKER, S</au><au>FRIEDHOFF, A. J</au><au>BRADBERRY, C. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of repeated amphetamine treatment on regional GABAA receptor binding</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1999-04-17</date><risdate>1999</risdate><volume>825</volume><issue>1-2</issue><spage>180</spage><epage>182</epage><pages>180-182</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>The present study examined the effects of repeated exposure to amphetamine on GABAA receptor binding in cortical and subcortical areas. The goal of the study was to determine whether changes in specific binding were related to behavioral sensitization. Animals were exposed to either saline (0.3 ml, s.c.; n=12) or d-amphetamine (2.5 mg/kg, s.c.; n=12) for 6 consecutive days and sacrificed after a 14-day withdrawal period. Differences in GABAA receptor binding in these two groups of animals were assessed using the GABAA receptor antagonist [3H]SR 95531. To verify that the preceding treatment regimen led to the development of behavioral sensitization, a separate set of animals (n=8/group) was exposed to the same regimen and challenged with d-amphetamine (2.5 mg/kg, s.c.) after the 14-day withdrawal period. As expected, preexposure to amphetamine led to the development of amphetamine sensitization. There were no differences in GABAA receptor binding in animals preexposed to saline and amphetamine in the prefrontal cortex, caudate-putamen, hypothalamus, or cerebellum. These findings do not provide support for the idea that changes in GABAA receptor binding in the medial prefrontal cortex or various subcortical areas are related to the development of behavioral sensitization.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier</pub><pmid>10216185</pmid><doi>10.1016/S0006-8993(99)01150-6</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-8993 |
ispartof | Brain research, 1999-04, Vol.825 (1-2), p.180-182 |
issn | 0006-8993 1872-6240 |
language | eng |
recordid | cdi_proquest_miscellaneous_69713876 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenergic Agents - pharmacology Amphetamine - pharmacology Animals Biological and medical sciences Brain Chemistry - drug effects Cerebellum - chemistry GABA Antagonists - pharmacology Hypothalamus - chemistry Locomotion - physiology Male Medical sciences Neostriatum - chemistry Neuropharmacology Pharmacology. Drug treatments Prefrontal Cortex - chemistry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Pyridazines - pharmacology Rats Rats, Sprague-Dawley Receptors, GABA-A - metabolism Receptors, GABA-A - physiology Tritium |
title | Effects of repeated amphetamine treatment on regional GABAA receptor binding |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T18%3A47%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20repeated%20amphetamine%20treatment%20on%20regional%20GABAA%20receptor%20binding&rft.jtitle=Brain%20research&rft.au=GRUEN,%20R.%20J&rft.date=1999-04-17&rft.volume=825&rft.issue=1-2&rft.spage=180&rft.epage=182&rft.pages=180-182&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(99)01150-6&rft_dat=%3Cproquest_cross%3E69713876%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69713876&rft_id=info:pmid/10216185&rfr_iscdi=true |